New Results

Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection

Anne C. Moore, Emery G. Dora, Nadine Peinovich, Kiersten P. Tucker, Karen Lin, Mario Cortese, Sean N. Tucker
doi: https://doi.org/10.1101/2020.09.04.283853

Article usage

Article usage: September 2020 to February 2023

AbstractFullPdf
Sep 2020805213041469
Oct 20201281466897
Nov 202081781189
Dec 2020866161156
Jan 2021961163272
Feb 202189793228
Mar 20215699499
Apr 202142434187
May 202146040109
Jun 202130537103
Jul 202124622856
Aug 20215091173141
Sep 2021615907181
Oct 202152968276
Nov 202120141752
Dec 202122927570
Jan 202220020449
Feb 202217514247
Mar 202218215441
Apr 202216611131
May 2022252136122
Jun 202221310335
Jul 20221459314
Aug 202212110625
Sep 20221259622
Oct 202215610115
Nov 202211717413
Dec 2022988816
Jan 20239111612
Feb 202326247
Back to top
Posted September 06, 2020.
Download PDF

Supplementary Material

Email
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
Anne C. Moore, Emery G. Dora, Nadine Peinovich, Kiersten P. Tucker, Karen Lin, Mario Cortese, Sean N. Tucker
bioRxiv 2020.09.04.283853; doi: https://doi.org/10.1101/2020.09.04.283853
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area